| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
CRC Experimental Chemotherapy Group, Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, United Kingdom
Animals given transplants of the MAC16 colon adenocarcinoma show a progressive decrease in carcass weight as the tumor size increases without a reduction in either fluid or caloric intake when compared with non-tumor-bearing controls. There is a decrease in both carcass fat and muscle mass which is directly proportional to the weight of the tumor. In male animals weight loss occurs when the tumor mass comprises more than 0.3% of the body weight and reaches 30% when the tumor represents 3% of the body weight.
There is evidence for the production by the tumor of both lipolytic and proteolytic factors, which may be responsible for the cachexia, since two related mouse adenocarcinomas, which do not produce weight loss, have little lipolytic or proteolytic activity. The lipolytic factor is nondialyzable and is destroyed by both heat and acid. Both insulin and 3-hydroxybutyrate suppress the lipolytic activity of the tumor extract. The MAC16 tumor also contains a serine protease, the activity of which is also completely abolished by insulin and 3-hydroxybutyrate. Animals bearing the MAC16 tumor have an elevated plasma lipolytic and proteolytic activity when compared with non-tumor-bearing controls, suggesting a peripheral effect of the tumor products. The catabolic factors elaborated by the MAC16 adenocarcinoma may be responsible for the loss of both the fat and nonfat carcass mass, but they do respond to normal metabolic controls.
1 This work has been supported by a grant from the Cancer Research Campaign.
2 Recipient of a research studentship from the Cancer Research Campaign.
Received 4/10/87. Revised 8/ 6/87. Accepted 8/13/87.
This article has been cited by other articles:
![]() |
P. T. Todorov, S. M. Wyke, and M. J. Tisdale Identification and Characterization of a Membrane Receptor for Proteolysis-Inducing Factor on Skeletal Muscle Cancer Res., December 1, 2007; 67(23): 11419 - 11427. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Siddiqui, D. Pandya, K. Harvey, and G. P. Zaloga Nutrition Modulation of Cachexia/Proteolysis Nutr Clin Pract, April 1, 2006; 21(2): 155 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Monitto, S.-M. Dong, J. Jen, and D. Sidransky Characterization of a Human Homologue of Proteolysis-Inducing Factor and Its Role in Cancer Cachexia Clin. Cancer Res., September 1, 2004; 10(17): 5862 - 5869. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. McCarthy Rethinking Nutritional Support for Persons with Cancer Cachexia Biol Res Nurs, July 1, 2003; 5(1): 3 - 17. [Abstract] [PDF] |
||||
![]() |
A. S. Whitehouse, H. J. Smith, J. L. Drake, and M. J. Tisdale Mechanism of Attenuation of Skeletal Muscle Protein Catabolism in Cancer Cachexia by Eicosapentaenoic Acid Cancer Res., May 1, 2001; 61(9): 3604 - 3609. [Abstract] [Full Text] |
||||
![]() |
C. Bing, M. Brown, P. King, P. Collins, M. J. Tisdale, and G. Williams Increased Gene Expression of Brown Fat Uncoupling Protein (UCP)1 and Skeletal Muscle UCP2 and UCP3 in MAC16-induced Cancer Cachexia Cancer Res., May 1, 2000; 60(9): 2405 - 2410. [Abstract] [Full Text] |
||||
![]() |
S.-S. Yeh and M. W Schuster Geriatric cachexia: the role of cytokines Am. J. Clinical Nutrition, August 1, 1999; 70(2): 183 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Tisdale Wasting in Cancer J. Nutr., January 1, 1999; 129(1): 243S - 243S. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kuno, N. Kanada, E. Nakashima, F. Fujiki, F. Ichimura, and K. Matsushima Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene J. Biol. Chem., January 3, 1997; 272(1): 556 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Mcnamara, H. R. Alexander, and J. A. Norton Cytokines and Their Role in the Pathophysiology of Cancer Cachexia JPEN J Parenter Enteral Nutr, November 1, 1992; 16(6_suppl): 50S - 55S. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |